A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Seagen Inc.
Seagen Inc.
A2 Biotherapeutics Inc.
A2 Biotherapeutics Inc.
Takeda
VM Oncology, LLC
Bristol-Myers Squibb
Actym Therapeutics, Inc.
Travera Inc
TCR2 Therapeutics
A2 Biotherapeutics Inc.
BerGenBio ASA
Travera Inc
NGM Biopharmaceuticals, Inc
UTC Therapeutics Inc.
Pfizer
NGM Biopharmaceuticals, Inc
Quadriga Biosciences, Inc.
MacroGenics
Shenzhen BinDeBio Ltd.
Morphotek
INSYS Therapeutics Inc
Anza Therapeutics, Inc.